The FDA is piloting real-time clinical trial monitoring while UCLA researchers have developed SEE-CITE, a molecular probe upgrade that maps drug-protein binding more precisely. Together, these ...
Q1 2026 Management View "We delivered a solid Q1 and continue to improve our say-to-do ratio with disciplined execution across the business" (CEO & Chairman Christopher Boerner). "In the quarter, ...
An event is scheduled this weekend to benefit an initiative that helps family members find loved ones with Alzheimer’s, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results